ENDOMEDITSINA, OOO, Nizhny Novgorod Oblast

Accounting reports

Previously

Name	ENDOMEDITSINA, OOO
INN	5260405030
KPP	526001001
OGRN	1155260001566
Address	603005, oblast' Nizhegorodskaya, g. Nizhniy Novgorod, ul. Varvarskaya, d. D. 6A, of. OFIS 2

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities ENDOMEDITSINA, OOO according to EGRUL
46.46	Core activity	Wholesale of pharmaceutical goods
33.13	Additional activity	Repair of electronic and optical equipment
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
All types of activities
52.29	Additional activity	Service activities incidental to land transportation
68.20.2	Additional activity	Renting and operating of own or leased commercial properties and non- residential buildings
70.22	Additional activity	Advice on business and management

Registration information

Registration date	10.02.2015
Registering department	Inspektsiya Federal'noy nalogovoy sluzhby po Nizhegorodskomu rayonu g.Nizhnego Novgoroda

Description

ENDOMEDITSINA, OOO (Nizhny Novgorod Oblast; INN 5260405030) was registered on 10 Feb 2015. The company's authorized capital as of July 1, 2012 was 10000 rub.

Principal activities of ENDOMEDITSINA, OOO: wholesale of pharmaceutical goods (46.46), repair of electronic and optical equipment (33.13), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74).

Industry

Economic indicators

2022

Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2022 1.58 times to 62.26 million RUB from 39.31 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 41.84% to 256.79 million RUB from 181.03 million RUB over 2021; cost of goods sold grew by 38.71% to 165.84 million RUB from 119.56 million RUB; sales profit went up 1.54 times to 79.72 million RUB from 51.89 million RUB.

2021

Net profit (RAS) of ENDOMEDITSINA, OOO dropped in 2021 by 15.91% to 39.31 million RUB from 46.74 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period by 11.95% to 181.03 million RUB from 205.59 million RUB in 2020; cost of goods sold decreased by 10.80% to 119.56 million RUB from 134.04 million RUB; sales profit fell by 16.15% to 51.89 million RUB from 61.88 million RUB.

2020

Net profit (RAS) of ENDOMEDITSINA, OOO dropped in 2020 by 11.81% to 46.74 million RUB from 53.00 million RUB over the same period in 2019, the company informed.

Revenue decreased in the accounting period by 0.55% to 205.59 million RUB from 206.72 million RUB in 2019; cost of goods sold grew by 1.60% to 134.04 million RUB from 131.93 million RUB; sales profit fell by 9.57% to 61.88 million RUB from 68.43 million RUB.

2019

Net profit (RAS) of ENDOMEDITSINA, OOO dropped in 2019 by 1.41% to 53.00 million RUB from 53.76 million RUB over the same period in 2018, the company informed.

Revenue increased in the accounting period by 13.29% to 206.72 million RUB from 182.48 million RUB over 2018; cost of goods sold grew by 19.74% to 131.93 million RUB from 110.18 million RUB; sales profit fell by 1.24% to 68.43 million RUB from 69.29 million RUB.

2018

Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2018 by 37.81% to 53.76 million RUB from 39.01 million RUB over 2017, the company informed.

Revenue increased in the accounting period by 45.10% to 182.48 million RUB from 125.76 million RUB over 2017; cost of goods sold grew 1.51 times to 110.18 million RUB from 73.07 million RUB; sales profit went up by 38.82% to 69.29 million RUB from 49.91 million RUB.

2017

Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2017 by 33.86% to 39.01 million RUB from 29.14 million RUB over 2016, the company informed.

Revenue increased in the accounting period by 9.38% to 125.76 million RUB from 114.97 million RUB over 2016; cost of goods sold decreased by 1.56% to 73.07 million RUB from 74.23 million RUB; sales profit went up by 37.23% to 49.91 million RUB from 36.37 million RUB.

2016

Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2016 5.86 times to 29.14 million RUB from 4.98 million RUB over 2015, the company informed.

Revenue increased in the accounting period 4.60 times to 114.97 million RUB from 25.01 million RUB over 2015; cost of goods sold grew 4.41 times to 74.23 million RUB from 16.82 million RUB; sales profit went up 5.79 times to 36.37 million RUB from 6.28 million RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 196 067

Reports

17 430 832

Rrocessed requests

Extract from EGRUL:

Today, 11:36 AM

Accounting reports:

Today, 11:37 AM